Attached files
| file | filename |
|---|---|
| 10-K - FORM 10-K - OxySure Therapeutics, Inc. | v306617_10k.htm |
| EX-32 - EXHIBIT 32 - OxySure Therapeutics, Inc. | v306617_ex32.htm |
| EX-31.2 - EXHIBIT 31.2 - OxySure Therapeutics, Inc. | v306617_ex31-2.htm |
| EX-31.1 - EXHIBIT 31.1 - OxySure Therapeutics, Inc. | v306617_ex31-1.htm |
| EX-10.45 - EXHIBIT 10.45 - OxySure Therapeutics, Inc. | v306617_ex10-45.htm |
| EX-10.4.4 - EXHIBIT 10.4.4 - OxySure Therapeutics, Inc. | v306617_ex10-4x4.htm |
| EX-10.5.3 - EXHIBIT 10.5.3 - OxySure Therapeutics, Inc. | v306617_ex10-5x3.htm |
| EX-10.6.3 - EXHIBIT 10.6.3 - OxySure Therapeutics, Inc. | v306617_ex10-6x3.htm |
| EX-10.44.1 - EXHIBIT 10.44.1 - OxySure Therapeutics, Inc. | v306617_ex10-44x1.htm |
| EXCEL - IDEA: XBRL DOCUMENT - OxySure Therapeutics, Inc. | Financial_Report.xls |
We consent to the inclusion in this Annual Report (Form 10-K) of OxySure Systems, Inc. of our report dated March 27, 2012, with respect to its balance sheet as of December 31, 2011 and 2010, and the related statements of operations, stockholders' equity (deficit), and cash flows for the years then ended to be included in this Annual Report.
| /s/ Sam Kan & Company | |
| Firm’s Manual Signature | |
| Alameda, CA | |
| City, State | |
| March 30, 2012 | |
| Date |